The 23rd Annual International Ultmann Chicago Lymphoma Symposium (IUCLS) is scheduled for April 10–11, 2026, at the JW Marriott Chicago in Chicago, IL.

This premier CME-accredited conference honors the legacy of Dr. John Ultmann by providing a specialized forum for oncologists, hematologists, and researchers to discuss the latest biologic and therapeutic advancements in Hodgkin and non-Hodgkin lymphoma. The 2026 program focuses on evaluating clinical trial results for novel therapies, optimizing treatment sequencing for relapsed or refractory cases, and developing patient-centered communication strategies.

Hosted by Bio Ascend in collaboration with the University of Chicago, the symposium offers participants critical updates on emerging treatment options, including the management of CLL/SLL, to ensure the integration of the latest research into clinical practice.